Characterization of HSV Derived AAV9 Vectors

被引：0
|
作者：
Pechan, Peter [1 ]
Golebiowski, Diane [1 ]
Seregin, Alexey [1 ]
Zapata, Nicole [1 ]
Levi, Elise [2 ]
Kitsos, Christine [2 ]
Lu, Robert [2 ]
Amorrortu, Alvaro [3 ]
Morris, Carl [1 ]
机构：
[1] Solid Biosci, Dev, Cambridge, MA USA
[2] Solid Biosci, PD, Cambridge, MA USA
[3] Solid Biosci, Operat, Cambridge, MA USA
来源：
MOLECULAR THERAPY | 2019年 / 27卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
737
引用
收藏
页码：347 / 347
页数：1
相关论文
共 50 条
  • [41] Identification of the Galactose Binding Domain of the AAV9 Capsid
    Bell, Christie L.
    Gurda, Brittney L.
    Van Vliet, Kim
    Agbandje-McKenna, Mavis
    Wilson, James M.
    [J]. MOLECULAR THERAPY, 2012, 20 : S4 - S4
  • [42] Intravascular delivery of AAV9 vectors into adult and neonatal mice display transgene expression differences in transduced organs
    Mateu-Bosch, A.
    Segur-Bailach, E.
    Garcia-Villoria, J.
    Ribes, A.
    Fillat, C.
    [J]. HUMAN GENE THERAPY, 2022, 33 (23-24) : A176 - A176
  • [43] Widespread vector distribution following intra-CSF delivery of AAV9 vectors in a large animal model
    Haurigot, Virginia
    Marco, Sara
    Ribera, Albert
    Garcia, Miquel
    Ruzo, Albert
    Villacampa, Pilar
    Ayuso, Eduard
    Anor, Sonia
    Andaluz, Anna
    Pineda, Mercedes
    Garcia Fructoso, Gemma
    Molas, Maria
    Maggioni, Luca
    Motas, Sandra
    Ruberte, Jesus
    Mingozzi, Federico
    Pumarola, Marti
    Bosch, Fatima
    [J]. HUMAN GENE THERAPY, 2012, 23 (10) : A47 - A47
  • [44] AAV9 Attenuates Neuromuscular Pathology in Pompe Disease
    Todd, A. Gary
    McElroy, Jessica A.
    Grange, Robert W.
    Fuller, David D.
    Walter, Glenn A.
    Byrne, Barry J.
    Darin, Falk J.
    [J]. MOLECULAR THERAPY, 2014, 22 : S155 - S155
  • [45] Engineered AAV9 Variants for Efficient Muscle Transduction
    Li, Shaoyong
    Chen, Shuyuan
    Li, Zhongwan
    Zhang, Runyuan
    Lan, Xing
    Jiang, Yuling
    Zheng, Yanyan
    Wan, Changpeng
    Pang, Xiaodong
    Wang, Lijun
    Ye, Guo-Jie
    Wu, Zhenhua
    [J]. MOLECULAR THERAPY, 2023, 31 (04) : 410 - 411
  • [46] Axonal transport of AAV9 in nonhuman primate brain
    Green, F.
    Samaranch, L.
    Zhang, H. S.
    Manning-Bog, A.
    Meyer, K.
    Forsayeth, J.
    Bankiewicz, K. S.
    [J]. GENE THERAPY, 2016, 23 (06) : 520 - 526
  • [47] coAAV Vectors from the AAV-Ligand Conjugate (ALIGATERT) Platform Outperform AAV9 to Address Neurological Disorders via CSF Delivery
    Gougerot, Alexianne
    Savy, Adrien
    Thomasson, Nitza
    Kara-Ali, Kamelia
    Kunalingam, Lavaniya
    Juricek, Ludmila
    Vidal, Patrice
    Lefevre, Gaelle M.
    [J]. MOLECULAR THERAPY, 2023, 31 (04) : 526 - 526
  • [48] Targeting glioblastoma with nanobody-displaying AAV9
    Jargalsaikhan, S.
    Richter, N.
    Schaefer, W.
    Maire, C.
    Mohme, M.
    Lamszus, K.
    Piaggio, F.
    Malatesta, P.
    Thirion, C.
    Koch-Nolte, F.
    Mann, A. M.
    [J]. HUMAN GENE THERAPY, 2022, 33 (23-24) : A41 - A41
  • [49] Thermostability and in vivo performance of AAV9 in a film matrix
    Doan, Trang Nguyen Kieu
    Le, Matthew D.
    Bajrovic, Irnela
    Celentano, Lorne
    Krause, Charles
    Balyan, Haley Grooms
    Svancarek, Abbie
    Mote, Angela
    Tretiakova, Anna
    Samulski, R. Jude
    Croyle, Maria A.
    [J]. COMMUNICATIONS MEDICINE, 2022, 2 (01):
  • [50] Thermostability and in vivo performance of AAV9 in a film matrix
    Trang Nguyen Kieu Doan
    Matthew D. Le
    Irnela Bajrovic
    Lorne Celentano
    Charles Krause
    Haley Grooms Balyan
    Abbie Svancarek
    Angela Mote
    Anna Tretiakova
    R. Jude Samulski
    Maria A. Croyle
    [J]. Communications Medicine, 2
12345